Add Yahoo as a preferred source to see more of our stories on Google. (Photo: Pabst) Pabst Blue Ribbon is once again releasing an unfathomably large beer pack. And this time around, it’s monstrous in ...
Amgen AMGN announced that it has acquired U.K.-based private biotech company, Dark Blue Therapeutics, for approximately $840 million. The acquisition will strengthen Amgen’s oncology pipeline by ...
Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myeloid Leukemia Acquisition brings a new therapeutic mechanism to Amgen's ...
Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its organization. The California pharma has stitched together a deal worth up to $840 ...
THOUSAND OAKS, Calif. - Amgen (NASDAQ:AMGN) announced Tuesday it has acquired Dark Blue Therapeutics Ltd., a privately held UK biotechnology company specializing in small molecule-targeted protein ...
Amgen's acquisition of Dark Blue Therapeutics focuses on DBT 3757, a promising therapy for AML and ALL, valued at over $840 million. DBT 3757 targets MLLT1/3 proteins, offering potential as a first-in ...
This article first appeared on GuruFocus. Amgen (NASDAQ:AMGN) has agreed to acquire UK-based cancer drug developer Dark Blue Therapeutics in a deal valued at up to $840 million, as the company looks ...
In what is thought to be the first major pharma M&A deal of the year, Amgen has bought Oxford, UK-based biotech Dark Blue Therapeutics (DBT), which specialises in cancer therapies. The transaction – ...
As the Los Angeles Rams prepare to play the Seattle Seahawks in a massive game for the NFC West, they will also be debuting some new uniforms. The Rams are the latest NFL team to unveil their "Rivalry ...
Happy Hockey Holidays to you and yours! Get the Blue Jackets fan in your life the perfect gift this holiday season with the CBJ Holiday Gift Pack, presented by HOMAGE. Purchasers will receive two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results